IMC Chicago LLC Has $338,000 Stock Position in VanEck Pharmaceutical ETF $PPH

Posted by Brian Himes on Jul 17th, 2026

IMC Chicago LLC reduced its stake in VanEck Pharmaceutical ETF (NASDAQ:PPH – Free Report) by 80.3% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,257 shares of the company’s stock after selling 13,292 shares during the period. IMC Chicago LLC’s holdings in VanEck Pharmaceutical ETF were worth $338,000 at the end of the most recent quarter.

Other institutional investors have also made changes to their positions in the company. AlphaCore Capital LLC bought a new stake in VanEck Pharmaceutical ETF in the fourth quarter valued at about $31,000. Group One Trading LLC bought a new position in VanEck Pharmaceutical ETF during the fourth quarter worth about $36,000. IFP Advisors Inc boosted its holdings in VanEck Pharmaceutical ETF by 53.7% during the third quarter. IFP Advisors Inc now owns 438 shares of the company’s stock worth $40,000 after buying an additional 153 shares during the last quarter. Advisory Services Network LLC acquired a new position in shares of VanEck Pharmaceutical ETF during the 3rd quarter worth about $41,000. Finally, EFG International AG acquired a new position in shares of VanEck Pharmaceutical ETF during the 4th quarter worth about $44,000.

VanEck Pharmaceutical ETF Price Performance

Shares of PPH stock opened at $109.88 on Friday. The stock has a market cap of $943.87 million, a PE ratio of 20.21 and a beta of 0.46. The stock has a 50-day moving average of $105.51 and a 200-day moving average of $105.41. VanEck Pharmaceutical ETF has a one year low of $81.74 and a one year high of $112.58.

VanEck Pharmaceutical ETF Cuts Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, July 7th. Investors of record on Wednesday, July 1st were issued a dividend of $0.6248 per share. The ex-dividend date was Wednesday, July 1st. This represents a $2.50 dividend on an annualized basis and a yield of 2.3%.

About VanEck Pharmaceutical ETF

(Free Report)

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.